Works by Bornet, Charléric

Results: 5
    1
    2
    3
    4

    Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.

    Published in:
    2016
    By:
    • Loret, Erwann P.;
    • Darque, Albert;
    • Jouve, Elisabeth;
    • Loret, Elvenn A.;
    • Nicolino-Brunet, Corinne;
    • Morange, Sophie;
    • Castanier, Elisabeth;
    • Casanova, Josiane;
    • Caloustian, Christine;
    • Bornet, Charléric;
    • Coussirou, Julie;
    • Boussetta, Jihen;
    • Couallier, Vincent;
    • Blin, Olivier;
    • Dussol, Bertrand;
    • Ravaux, Isabelle
    Publication type:
    Correction Notice
    5

    Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.

    Published in:
    Retrovirology, 2016, v. 13, p. 1, doi. 10.1186/s12977-016-0251-3
    By:
    • Loret, Erwann P.;
    • Darque, Albert;
    • Jouve, Elisabeth;
    • Loret, Elvenn A.;
    • Nicolino-Brunet, Corinne;
    • Morange, Sophie;
    • Castanier, Elisabeth;
    • Casanova, Josiane;
    • Caloustian, Christine;
    • Bornet, Charléric;
    • Coussirou, Julie;
    • Boussetta, Jihen;
    • Couallier, Vincent;
    • Blin, Olivier;
    • Dussol, Bertrand;
    • Ravaux, Isabelle
    Publication type:
    Article